Shanghai Stock Analysis

Crucial Technical Analysis Released on Kangmei Pharmaceutical Co., Ltd (600518) (2019-07-12)

Firstly, as of today (2019-07-12) we’ve determined the following resources to be extremely useful for Kangmei Pharmaceutical Co., Ltd investors – we recommend taking a look. Take your time with the following:

Beat The Market Analyzer: (this is a fantastic tool – use this to analyze Kangmei Pharmaceutical Co., Ltd in much more depth)
MM Publishing:
Trading Code:
Trader HR:

REPORTING FOR 2019-07-12 | TALLAHASSEESCENE.COM: We have conducted a deep analysis of how Kangmei Pharmaceutical Co., Ltd (600518) has been trading over the last 2 weeks and the past day especially. On its latest session, Kangmei Pharmaceutical Co., Ltd (600518) opened at 3.51, reaching a high of 3.61 and a low of 3.45 before closing at a price of 3.61. There was a total volume of 92972634.0.

VOLUME INDICATORS: We saw an accumulation-distribution index of 11.91123, an on-balance volume of -3.44, chaikin money flow of 2.2 and a force index of 0.0759. There was an ease of movement rating of 0.00699, a volume-price trend of -0.39733 and a negative volume index of 1000.0.

VOLATILITY: We noted an average true range of 0.4624, bolinger bands of 3.58713, an upper bollinger band of 3.16287, lower bollinger band of 3.45, a bollinger high band indicator of 1.0, bollinger low band indicator of nan, a central keltner channel of 3.52333, high band keltner channel of 3.42333, low band keltner channel of 3.62333, a high band keltner channel indicator of 1.0 and a low band keltner channel indicator of 1.0. There was a donchian channel high band of 3.45, a donchian channel low band of 3.45, a donchian channel high band indicator of 1.0, and a donchian channel low band indicator of nan.

TREND: We calculated a Moving Average Convergence Divergence (MACD) of -0.00337, a MACD signal of -0.00187, a MACD difference of -0.0015, a fast Exponential Moving Average (EMA) indicator of 3.45, a slow Exponential Moving Average (EMA) indicator of 3.45, an Average Directional Movement Index (ADX) of unknown, an ADX positive of 20.0, an ADX negative of 20.0, a positive Vortex Indicator (VI) of 1.0, a negative VI of 1.0, a trend vortex difference of 0.3611, a trix of 3.58071, a Mass Index (MI) of 1.0, a Commodity Channel Index (CCI) of -66.66667, a Detrended Price Oscillator (DPO) of 0.25423, a KST Oscillator (KST) of -68.63254 and a KST Oscillator (KST Signal) of -68.63254 (leaving a KST difference of -10.12356). We also found an Ichimoku rating of 3.56, an Ichimoku B rating of 3.56, a Ichimoku visual trend A of 3.19519, an Ichimoku visual trend B of 3.22885, an Aroon Indicator (AI) up of 4.0 and an AI indicator down of 4.0. That left a difference of -4.0.

MOMENTUM: We found a Relative Strength Index (RSI) of 50.0, a Money Flow Index (MFI) of 24.33486, a True Strength Index (TSI) of -100.0, an ultimate oscillator of -169.79592, a stochastic oscillator of 160.0, a stochastic oscillator signal of 160.0, a Williams %R rating of 60.0 and an awesome oscillator of -0.02217.

RETURNS: There was a daily return of -6.86325, a daily log return of -4.44518 and a cumulative return of -4.34783.

What the heck does all of this mean? If you are new to technical analysis, the above may be gibberish to you, and that’s OK (though we do advise learning these things). The bottom line is that AS OF 2019-07-12 (if you are reading this later, the analysis will be out of date), here is what our deep analysis of technical indicators are telling us for Kangmei Pharmaceutical Co., Ltd (600518)…

To stay up to date with what is happening here, we strongly advise Kangmei Pharmaceutical Co., Ltd investors to subscribe to’s daily email newsletter for updates, news and analyst ratings on stocks like Kangmei Pharmaceutical Co., Ltd – without this you are trading blind:

We will of course continue to cover the news and price action of Kangmei Pharmaceutical Co., Ltd, but it’s easiest for you to just subscribe to MarketBeat’s newsletter above so you don’t miss anything.

DISCLAIMER: We are not registered investment advisers and the above analysis should be taken at face value only. We strongly advise against buying or selling Kangmei Pharmaceutical Co., Ltd (600518) based solely on our analysis above, and are not responsible for any losses that you may incur if you choose make any investment decisions based on the above.

Abigale Lormen

Abigale is a Masters in Business Administration by education. After completing her post-graduation, Abigale jumped the journalism bandwagon as a freelance journalist. Soon after that she landed a job of reporter and has been climbing the news industry ladder ever since to reach the post of editor at Tallahasseescene.
Abigale Lormen

Latest posts by Abigale Lormen (see all)